Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Queensland Health
Cipla
US Department of Justice
Federal Trade Commission
Julphar
Healthtrust
AstraZeneca

Generated: December 16, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: nalidixic acid

« Back to Dashboard

NALIDIXIC ACID

CASRN: 389-08-2UNII: 3B

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Moodys
Colorcon
McKinsey
Cipla
Citi
Julphar
Cerilliant